Association of ANGPTL3 polymorphisms with high-density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease

Aghasizadeh, Malihe, Nosrati, Mina, Saberi-Karimian, Maryam, Safarian, Hamideh, Assadian, Parisa, Akbarpour, Ensieh, Sahebkar, Amirhosein, Avan, Amir, Ferns, Gordon A, Kazemi, Tooba, Miri-Moghaddam, Ebrahim and Ghayour-Mobarhan, Majid (2021) Association of ANGPTL3 polymorphisms with high-density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease. Journal of Clinical Laboratory Analysis, 35 (12). a23980 1-8. ISSN 0887-8013

[img] PDF - Published Version
Available under License Creative Commons Attribution-NonCommercial No Derivatives.

Download (349kB)

Abstract

Introduction
Previous studies have shown the importance of angiopoietin-like 3 (ANGPTL3) as a modulator of lipid profiles. Cholesterol uptake capacity (CUC) is one means for assessing high-density lipoprotein (HDL) functionality. This study for the first time has investigated the relationship between genetic ANGPTL3 polymorphism and CUC in patients with cardiovascular disease.

Methods
Five hundred three subjects comprising 350 healthy subjects and 153 individuals who developed a cardiovascular disease (CVD) event during follow-up were recruited as part of the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) cohort study. A modified CUC method was used to determine the CUC of serum samples. Applied amplification refractory mutation system PCR was performed for ANGPTL3 variants genotyping including: rs10789117, rs1748195, and rs11207997. Sanger sequencing was applied to confirm the genotypes.

Results
The results showed that there was a significant relationship between the rs1748195 genotypes and HDL concentration in the CVD group (p = 0.02). Moreover, individuals with a GG genotype of the rs1748195 were associated with a lower risk of CVD (OR = 0.49, 95% CI = 0.24–0.98, p = 0.04) compared with CC genotype in the CUC ≤ 1.7 a.u subgroup. Moreover, the CT genotype of rs11207997 was associated with a lower risk of CVD (OR = 0.74, 95% CI = 0.41–1.3, p = 0.01) compared with CC genotype in CUC > 1.7 a.u subgroup.

Conclusion
The results showed that the CT genotype of the rs11207997 variant was associated with a lower risk of incident CVD in patients with higher HDL functionality. As well, the rs1748195 gene variant may contribute to a reduced risk of CVD.

Item Type: Article
Keywords: angiopoietin-like protein, cardiovascular disease, cholesterol uptake capacity, polymorphism, Adult, Angiopoietin-Like Protein 3, Cardiovascular Diseases, Case-Control Studies, Cholesterol, Cholesterol, HDL, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide
Schools and Departments: Brighton and Sussex Medical School > Division of Medical Education
SWORD Depositor: Mx Elements Account
Depositing User: Mx Elements Account
Date Deposited: 29 Apr 2022 15:45
Last Modified: 29 Apr 2022 15:45
URI: http://sro.sussex.ac.uk/id/eprint/105581

View download statistics for this item

📧 Request an update